Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Halstead

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
JAMA|May 26, 1978
Oral polio vaccine. Effect of booster vaccination one to 14 years after primary seriesJ W Bass, S B Halstead, G W Fischer, et al.
Intervirology|January 11, 1975
Dengue carrier culture and antigen production in human lymphoblastoid linesJ S Sung, A R Diwan, W A Falkler, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1979
Absence of leukocytes permissive to dengue 2 virus in the acute phase of dengue hemorrhagic feverN J Marchette, T O'Rourke, R M Scott, et al.
Infection and Immunity|April 1, 1979
Effect of immune status on dengue 2 virus replication in cultured leukocytes from infants and childrenN J Marchette, S B Halstead, T O'Rourke, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1984
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. III. Reversion to virulence by passage of cloned virus in fetal rhesus lung cellsS B Halstead, N J Marchette, A R Diwan, et al.
American Journal of Epidemiology|November 1, 1984
Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreakN Sangkawibha, S Rojanasuphot, S Ahandrik, et al.
Lancet (London, England)|October 30, 1999
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic feverD M Watts, K R Porter, P Putvatana, et al.
AIDS Research and Human Retroviruses|December 1, 1993
Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trialsJ R Mascola, B J Mathieson, P M Zack, et al.
American Journal of Epidemiology|November 21, 2000
Epidemiologic studies on Dengue in Santiago de Cuba, 1997M G Guzmán, G Kouri, L Valdes, et al.
The Journal of Infectious Diseases|January 7, 1998
Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedulesT F Tsai, Y X Yu, L L Jia, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
JAMA|May 26, 1978
Oral polio vaccine. Effect of booster vaccination one to 14 years after primary seriesJ W Bass, S B Halstead, G W Fischer, et al.
Intervirology|January 11, 1975
Dengue carrier culture and antigen production in human lymphoblastoid linesJ S Sung, A R Diwan, W A Falkler, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1979
Absence of leukocytes permissive to dengue 2 virus in the acute phase of dengue hemorrhagic feverN J Marchette, T O'Rourke, R M Scott, et al.
Infection and Immunity|April 1, 1979
Effect of immune status on dengue 2 virus replication in cultured leukocytes from infants and childrenN J Marchette, S B Halstead, T O'Rourke, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1984
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. III. Reversion to virulence by passage of cloned virus in fetal rhesus lung cellsS B Halstead, N J Marchette, A R Diwan, et al.
American Journal of Epidemiology|November 1, 1984
Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreakN Sangkawibha, S Rojanasuphot, S Ahandrik, et al.
Lancet (London, England)|October 30, 1999
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic feverD M Watts, K R Porter, P Putvatana, et al.
AIDS Research and Human Retroviruses|December 1, 1993
Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trialsJ R Mascola, B J Mathieson, P M Zack, et al.
American Journal of Epidemiology|November 21, 2000
Epidemiologic studies on Dengue in Santiago de Cuba, 1997M G Guzmán, G Kouri, L Valdes, et al.
The Journal of Infectious Diseases|January 7, 1998
Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedulesT F Tsai, Y X Yu, L L Jia, et al.
Pageof 13